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Using the ROC Curve to Measure Association and Evaluate
Prediction Accuracy for a Binary Outcome
Research Article

Abstract
This review article addresses the ROC curve and its advantage over the odds ratio
to measure the association between a continuous variable and a binary outcome.
A simple parametric model under the normality assumption and the method
of Box-Cox transformation for non-normal data are discussed. Applications of
the binormal model and the Box-Cox transformation under both univariate and
multivariate inference are illustrated by a comprehensive data analysis tutorial.
Finally, a summary and recommendations are given as to the usage of the binormal
ROC curve.

Keywords: Odds ratio; Box-Cox transformation; Binormal ROC; AUC; Youden
index

Introduction
Logistic regression and its corresponding odds ratio(s) (OR)
are the most popular measure of association between a continuous
or categorical variable with a binary outcome in epidemiology.
For example, in epidemeology, we would be interested in the
association between health status and life style measures. For
a significantly associated predictor of a binary outcome, we can
estimate the probability of a random observation being in one
category and classify the observation into two groups based on
the value of the predictor. For example, it is believed that arsenic
exposure is associated with blackfoot disease. Such exposure can
be continuous, i.e., the level of chronic arsenic exposure through
drinking water, or binary, i.e., exposed versus non-exposed.
However, using logistic regression and the odds ratio sometimes
produces results that are puzzling and misleading: Kraemer
and Pepe et al. [1,2] provided very good discussions about the
paradoxical situations about the odds ratio, especially in the
presence of strongly associated predictors.
The odds ratio is the ratio between the odds of an outcome event
of interest in one category of the predictor variable versus the
odds of the same event in the other category of the predictor. For
example, the odds ratio of arsenic exposure for blackfoot disease
is defined as the ratio between the odds of getting the blackfoot
disease in the exposed group versus the odds in the non-exposed
group. Commonly, a variable associated with a binary outcome is
interpreted as a rule for classification or prediction of the binary
outcome. In order to predict or classify subjects into two categories,
a cut-off point/threshold is needed if the predictor is continuous.
Similarly, if the predictor is categorical with more than two levels,
then a grouping of neighboring categories is needed. For example,
in the field of medical diagnostics, some continuous biomarkers
that are associated with the disease outcome are used to identify
the sub-clinical diseased individuals. In medical diagnostics, it is
common to assume that the diseased subject generally has a larger
biomarker value than the healthy subject. In practice, sometimes
a transformation of the biomarker values is necessary in order to
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meet such assumption. For example, HIV patients generally have
lower CD4 cell counts, so we can transform the biomarker values
as the reciprocal of the CD4 cell counts. An individual receives a
positive diagnosis if his/her biomarker value of the diagnostic
test is greater than the threshold; otherwise the diagnosis is
considered “negative”. Generally, physicians determine the true
disease status by the long-established reference standard, which
is sometimes called the “gold standard”. Finally, for evaluation of
the prediction accuracy of a biomarker/diagnostic test for the
true disease status, a two-by-two association table is formed as
in Table 1.
In practice, the diseased and the healthy population
distributions generally overlap, which means there exist
diagnostic errors. The false negative (FN) is “those who have
disease and are diagnosed as negative” and the false positive (FP)
is “those who do not have disease and are diagnosed as positive”.
The corresponding correct cases are the true positive (TP) and
the true negative (TN), which are “those who have disease and are
diagnosed as positive” and “those who do not have disease and
are diagnosed as negative”, respectively. The proportion of true
positives among the diseased population is commonly referred
as the sensitivity and the proportion of true negatives among the
healthy population as the specificity. The sensitivity and specificity
characterize the diagnostic accuracy under the diseased and the
healthy populations, respectively. Mathematically, the sensitivity
and specificity are
Specificity =

TP
TP + FN

Specificity =

TP
TN + FP

The odds ratio in medical diagnostic setting is referred as
the diagnostic odds ratio (DOR), which is defined as the ratio of
the odds of a positive result of a diagnostic test in the diseased
population relative to that in the non-diseased population [3].
Equivalently, the DOR is the ratio of the odds of the disease among
the test positives versus that in the test negatives:
Biom Biostat Int J 2017, 5(3): 00134
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=
DOR

TP / FN TP / FP
= =
FP /TN FN /TN

sensitivity specificity
(1− sensitivity )(1− specificity )

Generally, an odds ratio of 1 indicates no association between
the predictor and the outcome. Therefore, a DOR=1 means that
the diagnostic test does not discriminate better than random
chance between the diseased patients and those without the
disease. The DOR rises steeply when one of the pair (sensitivity,
specificity) becomes nearly perfect, while the other one of the
pair may stay unsatisfactory. For example, when sensitivity = 0.99
and specificity = 0.5 , DOR = 99 .

However,

the

total

correct

classification rate is sensitivity + specificity =
1.49 which indicates
a moderate predictor for diagnosis. Furthermore, a large value
of the DOR sometimes have very wide confidence intervals.
Additionally, for a continuous predictor, in order to make a
prediction or a classification for a binary outcome, a cut-off point
or threshold value is needed which is usually estimated by some
optimization criteria. Bohning et al. [4] found that determining an
optimal cut-off value via maximizing the DOR might lead to optimal
cut-off estimates on the boundary of the parameter range, which
clearly is not an “optimal” cut-off value to use for classification. In
summary, a predictor with a large DOR does not necessarily yield
good prediction. Therefore, we need alternative approaches for
evaluating associations. In this paper, we recommend the use of
the Receiver Operating Characteristic (ROC) curve.
Table 1: Contingency table of reference standard versus diagnostic test
result
Reference standard

Diagnostic
test result

Positive

Diseased

Healthy

FN

TN

Negative

TP

FP

TP: True Positive; TN: True Negative; FP: False Positive; FN: False Negative

In the following, we introduce the basics of the ROC curve and
its summary indices in section 2. Section 3 present a parametric
approach for making inference for the ROC analysis using
binormal model under the assumption of binormality (i.e., both
the diseased and healthy populations are normally distributed).
In section 4, we discuss the use of the Box-Cox transformation for
non-normally distributed data. Section 5 illustrates the binormal
ROC analysis using a real data set. Finally we give a summary and
discussion in section 6.

Basics about the ROC Curve

For a continuous predictor, at each of the pre-specified
threshold values, paired values of sensitivity and specificity can
be computed. The Receiver Operating Characteristic (ROC) curve
is a graph plotting the pair of (1− specificity, sensitivity) for all
possible threshold values. Therefore, this graph demonstrates
a trade-off phenomena between sensitivity and specificity. The
ROC curve is an important and popular tool for the evaluation of
the diagnostic tests. It can be used to demonstrate associations
between a continuous variable for a binary outcome, as well as
help to evaluate the accuracy of the prediction and classification
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based on a continuous variable. Extensive statistical research has
been done in this field and there are several excellent reviews of
statistical methods involving ROC curves [5-8].

In theory, the ROC curve of a perfect diagnostic test would be
the one connecting points (0,0), (0,1) and (1,1). The point (0,1)
is sometimes referred as the perfection point. Some practitioners
may compare different diagnostic tests for the same disease
based on visual inspection of the estimated ROC curves that do not
overlap. The optimal test is the one with the ROC curve bending
most towards the perfection point. However, this is not applicable
for situations when the fitted ROC curves cross each other, which
frequently occurs in practice. Furthermore, even if the fitted ROC
curves do not overlap, due to sampling variability, such visual
inspection of the estimated ROC curves is still not a valid approach
to make formal comparisons between tests. Therefore, there is a
need for some type of formal index to summarize the ROC curve.
Among all summary measures of the ROC curve, the area under
the ROC curve (AUC) is very popular.
The AUC can be calculated by the integration of the ROC curve
with respect to the false positive rate over [0,1]. The AUC is an
overall summary of the ROC curve across all thresholds which
is invariant to the prevalence of the disease and the choice of
the diagnostic threshold. Under the assumption that a larger
biomarker value indicates greater likelihood of the disease, Bamber
and Donald [8] showed that the AUC equals the probability of the
marker value D of a randomly selected subject from the diseased
population being greater than the marker value H of a randomly
selected subject from the healthy population. This is denoted
as AUC
= Pr ( D > H ) . The AUC is more useful for evaluating a

diagnostic test at early stages, for which the primary purpose is to
pick up candidate tests with discriminating potentials. However,
as a single index, the AUC lacks details about the trade-off between
sensitivity and specificity, hence it cannot measure and balance
the respective cost of the false positives and the false negatives.
For different types of disease, the clinical-meaningful range of the
sensitivity and specificity would vary. Therefore, the partial area
under the ROC curve

( pAUC ) , which is obtained by integrating

the ROC curve over a predetermined range of the false positive
rate, would be more appropriate than the AUC for this purpose.
Alternatively, sensitivity at a predetermined false positive rate can
be used for specific applications.
For the purpose of making a diagnosis, a diagnostic threshold
for the test is required. As the AUC is a global summary measure
across all possible thresholds, separate computation after the
AUC evaluation is needed to derive the optimal cut-off point for
making diagnosis. Furthermore, the global measure AUC lacks
direct link to the sensitivity and specificity, hence it is rather
abstract for clinicians to understand and compute. For selecting
an “optimal” diagnostic cut-off point, there exist a variety of

approaches [10,11]. Among them, the Youden index J , defined
as max c {sensitivity ( c ) + specificity ( c ) −1} , is very popular since

it ties nicely into the ROC framework and it has a closed-form
solution under normality [12]. The cut-off point determined via
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the Youden index maximizes the overall correct classification rate
(i.e., sum of sensitivity and specificity) and assigns equal weight to
the sensitivity and the specificity. The Youden index has a clinical
interpretation as a direct measure of the maximum diagnostic
accuracy that a marker can achieve. Another advantage of the
Youden index over the AUC is that it can detect differences other
than in location while the AUC can only detect location differences
between the diseased and healthy samples [13]. Graphically,
the Youden index is the maximum vertical distance between
the ROC curve and the chance line. It measures the difference
of the diagnostic accuracy of a marker and that determined by
random chance. In order to give varying weights for sensitivity
and specificity, the weighted Youden index was proposed [14,15]

{

}

and is expressed as max c W *s ensitivity ( c ) + (1−W )*specificity ( c ) −1
with predetermined weights W and 1 − W .

Binormal Model for ROC Analysis

For the ROC analysis, sometimes, parametric assumptions
are made on the distributions of the marker measurements for
both healthy and diseased groups. The binormality assumption
is the most popular as it utilizes many properties of the
normal distribution and hence is the most straightforward for
applications in practice. When the two discriminating populations
are normally distributed or can be simultaneously transformed to
normal after some monotonic transformation, the corresponding
ROC curve satisfies the binormality assumption and is thus called
the binormal ROC curve [16-18]. Hanley [19] listed some primary
justifications of applying the binormal model for fitting the ROC
curves. These includes “Gaussian distribution is natural for many
situations”, “Other distributions can be approximated by Gaussian”,
“The ROC curve is invariant under monotonic transformation of
marker values” and “Mathematical convenience based on nice
properties of normality.” The binormal ROC model provides a basis
for parametric estimation and inference about the ROC curve and
its summary indices. The binormal model generally fits well for
continuous marker values. It is also robust for rating data on an
ordinal scale assuming a continuous latent variable under large
sample assumption [19]. This article focuses on the binormal
model fitted explicitly on the continuous biomarker values.
For making inference about the ROC curve using the binormal
model, Linnet [20] developed a parametric approach based on
maximum likelihood estimation for sensitivity given a fixed value
of specificity or false positive rate. The confidence interval about
sensitivity at a single value of specificity or false positive rate can
also be considered as the pointwise confidence interval for the ROC
curve. For making inference about the whole or partial ROC curve
and maintaining the type I error within the range of specificity,
the simultaneous confidence band needs to be estimated. Ma
and Hall [21] proposed a parametric confidence band of the
ROC curve by applying the binormal model and extending the
Working and Hotelling [22] confidence band for a regression line.
Demidenko [23] proposed an ellipse-envelope confidence band
under binormality for the ROC curve. Yin and Tian [24] proposed
a generalized inference confidence band for the ROC Curve.
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For the Youden index and its associated optimal cut-point,
some researchers examined different estimation and inference
methods under binormal assumption. For example, Fluss et al.
[25] compared parametric methods with and without the BoxCox transformation; Schisterman and Perkins [12] proposed
asymptotic confidence intervals based on bi-normal and bigamma models; Lai and Tian [26] applied the generalized
inference method. For making inference about the AUC using
the binormal model, Wieand et al. [27] applied the delta method
based asymptotic results to construct a test of difference between
two AUCs in a paired design. Molodianovitch et al. [28] applied the
Box-Cox transformation for non-normal data and then applied the
method of Wieand et al. [27] on the transformed data. Tian [29]
and Li et al. [30] applied the generalized pivotal quantity approach
to obtain the exact confidence intervals for single AUC and paired
AUC respectively. Recently, the parametric joint inference under
binormality for two or more ROC summary indices were proposed.
For example, Yin and Tian [30] proposed joint confidence
region estimation of the AUC and the Youden index based on the
asymptotic delta method and generalized inference approach.
Yin and Tian [31] and Bantis et al. [32] used similar approaches
for joint inference about sensitivity and specificity at the optimal
threshold value associated with the Youden index.

Under binormality
Let

(

Y1  Normal µ1 ,σ12

)

and

(

Y2  Normal µ2 ,σ 22

)

denote

diagnostic marker measurements for the diseased and the healthy

populations respectively. The cumulative distribution function
( t − µi )
(cdf) for the two populations is denoted as FYi ( t ) = Φ
for
σi
i = 1, 2 . Assume that y1 and y2 are independent. Without loss of

generality, assume that µ1 > µ2 . Zou and Hall [18] stated that the

ROC curve is completely determined by the parameters α and β
which are defined as
µ1 − µ2
σ1
					(1)
=
α =
and β
σ2
σ2
Under binormality, given the false positive rate
curve can be expressed as

( p ) , the ROC

 α + Φ −1 ( p ) 

ROC( p ) =
1 − FYi FY−21 (1 − p ) =
Φ


β



(

)

Sensitivity and specificity at any known threshold c are
expressed as
		

 µ −c
 c − µ2 
P1 ( c ) =
Φ  1
Φ 
 andP2 ( c ) =

						(2)
σ
 1 
 σ2 

where Φ (.) denotes
distribution function.

the

standard

normal

cumulative
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The optimal cut-point c0 associated with Youden index can

 c − µ2 
 c − µ1 
be obtained by maximizing J = Φ 
 − Φ 
 with
σ
2 

 σ1 
respect to c. Hence the optimal cut-point c0 is achieved at the
intersection of the two normal density functions of the healthy
and the diseased groups which gives largest separation of the two
populations. Denote the optimal threshold value associated with
the Youden index as c0 and it is obtained by

c0

{
}
argmax { FY 2 ( c ) + FY ( c )}

c arg max p1 ( c ) + p2 ( c ) − 1 (3)

=

		 =
=

1

c

Youden index ( J ) is

=
J FY2 ( c0 ) − FY1 ( co )

and the sensitivity (P1) and specificity (P2) at the optimal
threshold co selected by the Youden index are

P1 ( c0 ) =
1 − FY1 ( c0 ) ; P2 ( c0 ) =
FY2 ( C0 )

Schisterman and Perkins [11] presented the Youden index ( J )

and the optimal cut-off value ( c0 ) as functions of µi ' s and σ i ' s

( i = 1, 2 ) . Based on two binormal parameters in (1), we can derive

the Youden index as a function of α and β. When σ 1 ≠ σ 2 (i.e. β≠1),
co can be expressed as

(

)

(

) ( ) (4)

µ2 β 2 − 1 − ασ 2 + βσ 2 α 2 + β 2 − 1 ln β 2
						
c0 =
β 2 −1
and hence j is calculated to be

 µ −c 
 c − µ2
J = Φ  1 0  + Φ  0
					
 σ1 
 σ2

(

)

(

)


 − 1 (5)



2
2
2
 αβ − α + β − 1 ln β
= Φ
β 2 −1



2
2
2
 α − β α + β − 1 ln β
−Φ 
β 2 −1















When variances for the healthy and the diseased groups are
µ + µ2
the same and equal to σ 2 , i.e. β = 1 , then c0 = 1
and J can
2
be obtained correspondingly as
 µ − µ2
J = 2Φ  1
 2σ


α 
 − 1 = 2Φ  2  − 1
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The optimal cut-off point associated with the Youden index is
the only optimal estimation with a closed-form solution under
binormality. Therefore, among all cut-off point selection criteria,
the one based on the Youden index is the most straightforward
approach for clinicians to apply directly.
The AUC is calculated by integration of the ROC curve function
with respect to false positive rate (p) from 0 to 1:

(

)

1
−1
AUC =
∫01 − FY1 FY2 (1 − p ) dp

β:

Under normality, AUC can be expressed as a function of α and


 α

µ − µ2 

AUC =
Φ 1
=
Φ
 σ2 σ2 
2 

						(6)
 1+ β 
 1 + 2 

Since all the aforementioned ROC indices have closed-form
solutions, which are functions of normal means and variances,
substituting the sample means and variances of the observed
data into corresponding expressions, e.g., (4), (5) and (6),
provides the large-sample estimates of these ROC indices. For
making inferences about these ROC indices, we must derive the
large-sample variances of these estimates. This can be achieved
by applying the large-sample delta method. However, there are
times such as when making a joint inference about several ROC
indices, when it is challenging and labor intensive to derive a
closed-form solution for the asymptotic variance matrix by the
large sample delta method. In such situations, some alternative
simulation based methods can be applied, such as the parametric
bootstrapping or the generalized inference approach based
on simulated generalized pivots [33,34]. After obtaining the
point estimate and the variance estimate of corresponding ROC
indices of interest, it is straightforward to derive the confidence
interval or region and the test statistics for hypothesis testing
using standard z-test type of approach for univariate case and
chi-square-test type of approach for multivariate case. There
may be times when the obtained confidence interval or region
is not bounded by the meaningful range of the ROC index. When
this happens, it is recommended to apply a logit or a arcsinsquare-root transformation for both univariate and multivariate
inference problems. Alternatively, if the parametric bootstrapping
or the generalized inference approach is applied, the lower and
upper limits of the confidence intervals can be estimated by the
quantiles of the simulated bootstrap samples or generalized
pivots.

The Box-Cox
binormality

transformation

for

cases

without

When normality is not satisfied, it is a standard practice to
use the Box-Cox transformation to approximate normality in
diagnostics due to the fact that the ROC curve is invariant under
monotonic transformations. This type of approach is very popular
and has been shown to perform very well for a wide variety of
situations in ROC studies [28,25,18,35-37]. For review of Box-Cox
transformation in general, see Sakia [38].
For the j th ( j =1,....,ni ) subject in the i th group (i=1,2) with each
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 Yijλ − 1

;λ ≠ 0
λ
Yij( ) =  λ1
					

					(7)
log Yij ; λ = 0

( )

(

)

i.i.d
λ
where it is assumed that Yij( )  N µi ,σ i2 . Based on the

observations from the healthy and the diseased group, the loglikelihood function can be simplified as follows:
		
2


Y (λ ) − µ 

 ij
i
2 ni  1
						

 + λ − 1 log Y 
2
∑ ∑  − log 2πσ i −
(
)
ij
 (8)
2σ i2
i j  2
						





(

)

The maximum likelihood estimate (MLE) of λ can be obtained
by maximizing the function in (8). As the same transformation
is used for both the diseased and the healthy populations,
we are required to take the same transformation for both
groups to approximate binormality. After applying the Box-Cox
transformation, the binormal-model based inference approaches
can be readily applied for the transformed data.
There are some alternative versions of Box-Cox transformation.
For example, only positive Y values are allowed in the BoxCox transformation equation in (7). In order to address such a
limitation, it is suggested to apply the shifted power transformation
[36] with the form

( λ1,λ2 )

Yij

λ1

−1
 Yij + λ2
,

=
λ1 ≠ 0 λ1 =
0
λ1

log Yij + λ2 ,

(

)

(

)

where λ1 is the Box-Cox transformation parameter and λ2 is a

( )

fixed value such that min Yij > −λ2 . This adjustment is the same
as moving the whole data distribution towards right by a value
of λ2 .

( )(

It is important to note that the range of Yij
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for univariate inference problems in the ROC analysis context.
However, it does not perform satisfactorily under multivariate
situations [13,31] due to the lack of consideration of the variability
of λ, when the Box-Cox transformation completely separates from
the estimation process under binormality using the delta method.

group having ni observations, let
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λ)

is restricted

according to whether λ is positive or negative. This implies that
the transformed values do not cover the entire real line, which
provides only approximate normality for the Box-Cox transformed
data set.

For non-normal data, researchers generally apply the BoxCox transformation first to approximate binormality for the
original data and then the binormal model is applied based on
the transformed approximately normal data. Therefore, the
parameter λ is assumed to be fixed when applying the binormal
model and the delta method. Bantis et al. [32] discussed that as λ
is a parameter in the likelihood function, the information matrix
should include it in addition to the normal means and variances,
resulting in an information matrix of the normal parameters
that is no longer diagonal. It has been shown to perform well

In order to take into account the variability of λ , Bantis et al.
[32] proposed to apply the standard asymptotic delta method
incorporating λ in the information matrix of normal means and
variances in order to calculate the variance of the corresponding
ROC index/indices. Alternatively, they proposed to generate
bootstrap samples parametrically under binormality to allow λ
to vary for each bootstrap sample, and then use the transformed
samples to calculate the bootstrap variance matrix. They
demonstrated significant improvements through a simulation
study in terms of the coverage probability of the proposed
confidence region of sensitivity and specificity at the optimal cutoff point associated with Youden index when taking the variability
of λ into account. Even though empirically, the performance of BoxCox transformation under univariate case is satisfactory and not
as sensitive as the multivariate case, the process assuming fixed
λ is theoretically not sound. Therefore, we recommend future
researchers to take into account of the variability of λ when
calculating the variances of the ROC indices for both univariate
and multivariate scenarios in ROC analysis.

Data Example of Binormal ROC analysis

Duchenne muscular dystrophy (DMD) is a recessive X-linked
form of a genetic disorder. It is characterized by progressive
muscular degeneration and weakness. It is caused by the mutation
in the gene for dystrohin, which is a protein found in the muscle.
Because of the way the disease is inherited, the female carriers are
unaware of this mutation until they have an affected son. Percy
et al. [39] presented data of four different DMD markers, namely
serum creatine kinase (CK), hemopexin (HPX), pyruvate kinase
(PK) and lactate dehydrogenase (LD). Complete data is available
on 66 female carriers with affected sons and 127 female controls.
For illustrative purposes, markers CK and HPX are used in this
section.

Figures 1 and 2 presents Q-Q plots of markers CK and HPX,
respectively, for the control and carrier groups. It can be seen that
marker HPX is normally distributed for both groups, while marker
CK is not. The Box-Cox transformation is applied for marker
CK and the estimate of the Box-Cox parameter λ is obtained by
maximizing the log-likelihood function of the data set as in (8),
which is estimated to be −0.345. Figure 3 give the Q-Q plots of
the Box-Cox transformed CK marker values, and we can see
that both diseased and healthy groups are normally distributed.
The binormal model is applied on the Box-Cox transformed CK
values and the original HPX values. Both the binormal and the
non-parametric empirical ROC curves are estimated and the
corresponding Working Hotelling [22] type of confidence band
is plotted with the empirical and the binormal ROC curves (see
Figures 4 and 5). The reason for the confidence band being narrow
is due to the relatively large sample sizes of this data set. We will
use the Box-Cox transformed CK marker values for illustrating the
univariate inferences in the ROC context and HPX marker for the
multivariate inferences.

Citation: Yin J, Vogel RL (2017) Using the ROC Curve to Measure Association and Evaluate Prediction Accuracy for a Binary Outcome. Biom Biostat Int J
5(3): 00134. DOI: 10.15406/bbij.2017.05.00134

Copyright:
©2017 Yin et al.

Using the ROC Curve to Measure Association and Evaluate Prediction Accuracy for a
Binary Outcome

6/10

Table 2 gives the contingency table for marker CK at the cut-off point associated with the Youden index,
which can be calculated from (4) using the binormal model. For table 3, the optimal cut-off point for the
diagnosis based on marker CK is determined by maximizing the DOR or equivalently, the logarithm of DOR, i.e.,

  µ − c 
  c − µ2
cOR = max c log DOR ( c ) = log  Φ  1
  + log  Φ 

  σ1  
  σ2


(

)

  c − µ1  
  µ2 − c   

  − log  Φ 
  − log  Φ 
   . For this data set, the DOR does

  σ1  
  σ 2   

not reach its maximum within the observed range of cut-off point, so we select a point on the boundary. The maximum CK value of
2.6535 is chosen to be the optimal cut-off point. This situation is not rare, as Bohning et al. [4] concluded that the DOR criteria for
optimizing the cut-off point can “easily lead to cut-off point on the boundary of the parameter range”.
Youden index ( cJ ) and the maximum DOR ( cOR ) for marker CK.

When the cut-off point selected corresponds to the maximum
DOR, the estimate for the DOR is infinity and therefore, no valid
confidence interval can be calculated. Even at the optimal cut-off
point with the Youden index, the DOR estimate still has a relatively
wide confidence interval. However, both ROC indices, i.e., the AUC
and the Youden index always yield bounded confidence intervals
within the range of [0,1].

Figure 1: Q-Q plots of marker CK. Values from both the diseased and
the healthy groups are not normally distributed, therefore, Box-Cox
transformation is needed.

Figure 3: Q-Q plots of the Box-Cox transformed values of marker CK.
After Box-Cox transformation, the values from both the diseased and
the healthy groups are normally distributed.

Table 2: Contingency table of marker CK at the optimal cut-off point with
the Youden index ( c j = 2.1837 )
Diagnostic

Figure 2: Q-Q plots of marker HPX. Values from both the diseased and
the healthy groups are normally distributed.

Table 4 summarizes the point and interval estimates for the
AUC, the Youden index ( J ) and the diagnostic odds ratios (DOR)
at the optimal cut-off point corresponding to the maximum

test result1

>2.1837

≤2.1837

Diseased

Healthy

19

110

47

17

1: The diagnosis is based on the Box-Cox transformed marker value

In Figure 7, the joint confidence region of the sensitivity
and the specificity at the optimal cut-off point associated with
the Youden index are plotted for marker HPX, along with the
rectangular region formed by respective confidence intervals of
the sensitivity and the specificity after the Bonferroni correction.
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The Bonferroni-corrected method is commonly used for adjusting
multiple testing in practice due to its straightforward application.
However, it is known to give conservative results. Similarly, Figure
8 gives the joint confidence region of the AUC and the Youden
index for marker HPX along with the rectangular Bonferroni
region. From Figure 8, since the correlation between the AUC
and the Youden index is very high, the advantages of the joint
confidence region are significant.

Figure 6: Logarithm of the DOR values across all possible values of
the cut-off point for marker CK of the data set

Figure 4: The estimated binormal ROC curve (bold), empirical ROC
curve (step line) and the 95% confidence bands (CB) of the ROC curve.
The binormal ROC curve and the corresponding Working Hotelling
confidence band [22] are fitted on the Box-Cox transformed values
of marker CK.

Table 3: Contingency table of marker CK at the optimal cut-off point with
the maximum DOR (cOR = 2.6535)
Diseased

Healthy

Diagnostic

> 2.65352

0

0

test result1

≤2.6535

66

127

1:The diagnosis is based on the Box-Cox transformed marker value.
2:Since the DOR does not reach its maximum within the observed range
of cut-off point (as shown in Figure 6), the maximum CK value (2.6535) is
thus chosen to be the optimal cut-off point.
Table 4: Summary of point and interval estimates about the AUC, the

( J ) and the diagnostic odds ratios (DOR) at the optimal
cut-off point corresponding to the maximum Youden index ( cJ ) and the
maximum DOR ( cOR ) for marker CK.

Youden index

Figure 5: The estimated binormal ROC curve (bold), empirical ROC
curve (step line) and the 95% confidence bands (CB) of the ROC curve.
The binormal ROC curve and the corresponding Working Hotelling
confidence band [22] are fitted on the original values of marker HPX.

AUC

J

DOR ( cJ )

DOR ( cOR )

Point Est.

0.8721

0.6113

19.9650

inf

95% C.I.

(0.8157,
0.9284)

(0.5132,
0.7093)

(7.65 , 33.48)

-

1: The cut-off estimate is for the Box-Cox transformed CK values.
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Figure 7: The 95% joint confidence region of the sensitivity and the specificity at the optimal cut-off point associated with the Youden index
for marker HPX. Since both the sensitivity and the specificity are given at the same cut-off point which is estimated by all samples from the
two populations. Therefore, the sensitivity and the specificity at the optimal cut-off point are correlated (the sample correlation is −0.26 for
this data set). Meanwhile, the rectangular region formed by respective individual confidence intervals adjusted by the Bonferroni correction is
also plotted to compare with the joint elliptical region. The joint confidence region is estimated by the generalized inference approach, which
automatically account for the correlation structure through simulations. The joint confidence region is given by the elliptical equation 		

( x − 0.7590 )2 ( y − 0.6179 )2

				
+

0.1298

2

0.0956

2

=
1 with major axis being in the direction of vector ± (1, −1.7237 ) and with point (0.7590,0.6179) as
T

the origin. The individual confidence intervals are calculated by the lower and upper 0.05/4 percentiles of the simulated generalized pivotal
quantities. The 97.5% adjusted confidence interval for sensitivity is (0.6418,0.8370), and that for specificity is (0.4957,0.7188).

Figure 8: The 95% joint confidence region of the AUC and the Youden index and the rectangular region formed by respective individual
confidence intervals adjusted by the Bonferroni correction for marker HPX. The joint confidence region is estimated by the large sample delta
method, for which the variance matrix of AUC and Youden index is calculated analytically. The joint confidence region is given by the elliptical
equation

( x − 0.7523)2 + ( y − 0.3802 )2
0.18402

0.01462

=
1 with major axis being in the direction of vector ± (1,1.5975 ) and with point (0.7523,0.3802)
T

as the origin. The adjusted individual confidence intervals are calculated by the standard z-test at the confidence level of 97.5%, and it is
(0.6747,0.8300) for the AUC and (0.2571,0.5033) for the Youden index. Since the AUC and Youden index are highly correlated, the rectangular
region formed by Bonferroni approach is very conservative (as its area is much larger than that of the ellipse) and has less likelihood to
successfully reject the multivariate outliers (e.g., point (0.7,0.45) in red).
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Summary and Discussion
Logistic regression and its corresponding odds ratio are the
most popular measures of association between a continuous
or categorical variable with a binary outcome in epidemiology,
but it often produces results that are puzzling and misleading.
A predictor with a large DOR does not necessarily yield a good
prediction. Also, the DOR is not a proper measure of prediction
accuracy for a strongly associated variable since the DOR will be
very large and even close to infinity with wild confidence intervals.
Henceforth, we need alternative approaches for evaluating strong
association. In this paper, we recommend the use of the Receiver
Operating Characteristic (ROC) curve. The most straightforward
parametric approach to estimate the ROC curve and make
inference about the ROC curve and its related summary indices is
the binormal model.
The classical binormal model with two parameters has some
limitations. Specifically, it does not fit well for “degenerate” data
set. Metz and Pan [40] suggested that the fitted ROC curve by the
classical binormal model always lie partly below the diagonal
line, and such phenomena is especially obvious for degenerate
data. The sensitivity is not a monotonic increasing function with
respect to the false positive rate, as is supposed to be by the
ROC theory. Therefore, for such degenerate data, the binormal
ROC curve is not “proper”. Alternative parametric models were
proposed when the conventional binormal model is no longer
appropriate, including the “proper” binormal model [41] and the
“proper” bigamma model [41]. Particularly, the “proper” binormal
model contains three parameters by making diagnostic decisions
based upon some monotonic transformations of the likelihood
ratio of the bi-normally distributed random marker values. Unlike
the two-parameter classical binormal model, the ROC-related
indices may not have closed-form solutions expressed by the
three parameters, which can be an interesting problem for future
research.

When normality is not satisfied for either the diseased or
the healthy population, it is a common practice to use Box-Cox
transformation to achieve binormality in diagnostic studies.
This is achieved due to the fact that ROC curve is invariant under
monotonic transformations. An issue about the application of the
binormal model in the ROC context is that it is not a very robust
approach under violations of binormality assumption [42].
Sometimes it is impossible to approximate normality well enough
for both populations under a common transformation with the
same λ. In such situation, the non-parametric bootstrap methods
based on empirical estimates or kernel-smoothed estimates of the
ROC curves or its summary indices has been shown to perform
very well and are easily applied. For example, see Faraggi and
Reiser [35] [35]and Fluss et al. [25] for single indices, Yin and
Tian [13] and Bantis et al. [32] for joint inference.
If multiple variables are believed to associate with the
binary outcome of interest collectively but not individually, it
is recommended to combine the variables to a composite score
or function. In the context of the ROC analysis, researchers have
proposed combining the multiple predictors by maximizing the
ROC indices, such as the AUC or the Youden index [43-47,11]. After
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a composite score is obtained, the binormal model discussed here
is readily applied for the composite score to make inference about
the prediction accuracy when all variables are combined.
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